Zyloware unveils collection of 12 summer styles

Slideshow

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Nora Lee Cothran, OD, FAAO, moderated an Innovation Hub panel that featured 3 companies, giving insights into what's to come in the optometric industry.
Selina McGee, OD, shares what she wants to see in future State of Dry Eye surveys and how this year's results will affect her patient care.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
Clark Chang, OD, MSA, MSc, FAAO, gave a presentation alongside Susan Gromacki, OD, MS, FAAO, FSLS, at this year's Optometry's Meeting.
Selina McGee, OD, FAAO, Dipl ABO, shares key takeaways and a personal anecdote relating to the State of Dry Eye survey results.
Devin Sasser, OD, shares his excitement for Acuvue Oasys MAX 1-Day multifocal for astigmatism, the first and only daily disposable multifocal toric contact lens.
Reviewing the State of Dry Eye Survey with Selina McGee, OD, FAAO, Dipl ABO.
Related Content
Businessmen discussing numbers at table Image credit: AdobeStock/M+Isolation_Photo

New agreement to authorize Kowa Company to develop, manufacture Nicox's NCX 470 in US

Jordana Joy, Associate Editor
July 18th 2025
Article
Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

June 30th 2025
Podcast
FDA accepts Aldeyra Therapeutics' new drug application for reproxalap for review.

FDA accepts for review Aldeyra Therapeutics’ resubmitted new drug application for reproxalap

Martin David Harp, Editor, Ophthalmology Times
July 17th 2025
Article
Navigating the Glaucoma Therapeutic and Surgical Landscape from Conventional to Cutting Edge

Navigating the Glaucoma Therapeutic and Surgical Landscape from Conventional to Cutting Edge

June 30th 2025
Podcast
Association between ADHD and myopia among schoolchildren - Image credit: ©Studio Romantic—stock.adobe.com

Association between ADHD and myopia among schoolchildren

Lynda Charters
July 16th 2025
Article
Hands holding up trophy Image credit: AdobeStock/Shutter2U

EyeDura's eye drop technology recognized by eye care industry

Jordana Joy, Associate Editor
July 16th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.